FDA Adverse Event Injury Summary report: N

TWIIST AUTOMATED INSULIN DELIVERY SYSTEM

MDR report key: 25237304 · Received May 20, 2026

Report

Report Number
3016798778-2026-00137
Event Type
Injury
Date Received
May 20, 2026
Date of Event
April 16, 2026
Report Date
May 20, 2026
Manufacturer
MILLYARD ADVANCED MEDICAL PRODUCTS, LLC
Product Code
QFG
UDI-DI
00850017421400
PMA / PMN Number
K250930
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NH, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A SPECIFIC ROOT CAUSE FOR THE REPORTED EVENT CANNOT BE DETERMINED WITH THE INFORMATION AVAILABLE FOR ASSESSMENT. THE INVESTIGATION REMAINS ONGOING AND A SUPPLEMENTAL REPORT WILL BE FILED ONCE RESULTS ARE AVAILABLE. THE CURRENT VERSION OF THE TWIIST AUTOMATED INSULIN DELIVERY (AID) SYSTEM USER GUIDE PROVIDES INFORMATION REGARDING SYSTEM ALARMS AND THE RECOMMENDED ACTIONS ASSOCIATED WITH THEM, INCLUDING THE CGM HIGH GLUCOSE ALERT, AS WELL AS WAYS TO PREVENT HYPERGLYCEMIA. USERS ARE ALSO INSTRUCTED TO HAVE A BACKUP INSULIN THERAPY AVAILABLE AT ALL TIMES. THE CLEO 90 INFUSION SET IS DISTRIBUTED BY MILLYARD ADVANCED MEDICAL PRODUCTS, LLC, FOR USE WITH THE TWIIST AID SYSTEM. NO COMPONENTS OR ADDITIONAL INFORMATION RELEVANT TO THE REPORTED EVENT HAVE BEEN MADE AVAILABLE TO MILLYARD ADVANCED MEDICAL PRODUCTS, LLC, AT THIS TIME.

Description of Event or Problem · 0

AN INITIAL EVENT NOTIFICATION WAS RECEIVED BY SEQUEL MED TECH, LLC, ON 20-APR-2026 AND FORWARDED TO MILLYARD ADVANCED MEDICAL PRODUCTS, LLC ON THE SAME DAY. THE USER REPORTED THAT ON (B)(6) 2026, THEY CHANGED THEIR TWIST CASSETTE AND INFUSION SET AND BOLUSED FOR BREAKFAST "AS USUAL." AROUND NOON, THE USER NOTICED THAT THEIR GLUCOSE HAD INCREASED TO 400 MG/DL BUT THEY DID NOT TAKE ANY ACTION. THE USER REPORTED THAT DURING THE EVENING, THEY DID NOT EAT BUT BOLUSED THREE TIMES; HOWEVER, THEIR GLUCOSE REMAINED ELEVATED. BY 0100 ON (B)(6) 2026, THE USER BEGAN VOMITING BLOOD AND HAD SMALL KETONES. THE USER WAS ADMITTED TO THE HOSPITAL WHERE THEY WERE DIAGNOSED WITH DIABETIC KETOACIDOCIS AND CRITICAL KIDNEY INJURY. THE HOSPITAL STAFF REMOVED THE TWIST PUMP AND PLACED THE USER ON LANTUS AND HUMALOG INSULIN. THE USER DENIED RECEIVING ANY ALARMS FROM THE TWIIST PUMP AND STATED THAT IT HAD "TURNED OFF" AND LOOP WAS INACTIVE FOR SOME TIME. THE USER REPORTED THAT ON (B)(6) 2026, THEY ATTEMPTED TO USE THEIR TWIIST PUMP WITH A NEW CASSETTE AND INFUSION SET, BUT EXPERIENCED ELEVATED GLUCOSE LEVELS IN THE 400S MG/DL. THE USER ELECTED TO DISCONTINUE USE OF THE TWIIST SYSTEM AND PLANNED TO BE DISCHARGED ON MULTIPLE DAILY INJECTIONS (MDI).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
500232 TWIIST AUTOMATED INSULIN DELIVERY SYSTEM INFUSION PUMP QFG MILLYARD ADVANCED MEDICAL PRODUCTS, LLC DKPI-21073-007 00850017421400

Patients

Seq Age Sex Outcome Treatment
1